Japanese Red Cross Nagoya Daiichi Hospital
Nagoya, Aichi, Japan
General hospital in Nagoya
3 Chome-３５番地 Michishitacho, Nakamura Ward, Nagoya, Aichi 453-8511
About Japanese Red Cross Nagoya Daiichi Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
4
Ferring Pharmaceuticals
2
Society for Advancement of Coronary Intervention Research
2
Apellis Pharmaceuticals, Inc.
1
Canadian Cancer Trials Group
1
Coherus Biosciences, Inc.
1
Janssen Pharmaceutical K.K.
1
Jazz Pharmaceuticals
1
Kyowa Kirin Co., Ltd.
1
Takeda
1
Clinical Trials at Japanese Red Cross Nagoya Daiichi Hospital
During the past decade, Japanese Red Cross Nagoya Daiichi Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on
average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML
2008-02-05
2015-05-27
Completed
502
Study Evaluating SKI-606 (Bosutinib) In Japanese Subjects With Philadelphia Chromosome Positive Leukemias
2007-12-01
2015-06-01
Completed
63
Small Coronary Artery Treated by TAXUS Liberté Registry in Japan
2009-04-01
2012-08-01
Unknown status
250
Comparative Trial to Investigate the Dose-Response of 4 Different Dose Levels of Minirin Melt and Placebo
2010-07-01
2011-04-01
Completed
116
Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal Infection
2011-09-01
2013-05-01
Completed
21
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women
2012-09-01
2013-06-01
Completed
178
Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)
2014-05-01
2016-05-01
Completed
647
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Japanese Red Cross Nagoya Daiichi Hospital" #1 sponsor was "Pfizer" with 4 trials, followed by "Ferring Pharmaceuticals" with 2 trials
sponsored, "Society for Advancement of Coronary Intervention Research" with 2 trials sponsored, "Apellis Pharmaceuticals, Inc." with 1 trials sponsored and "Canadian Cancer Trials Group"
with 1 trials sponsored. Other sponsors include 0 different institutions and
companies that sponsored additional 10 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Japanese Red Cross Nagoya Daiichi Hospital"
#1 collaborator was "Australasian Lung Cancer Trials Group" with 1 trials as a collaborator, "Central and Eastern European Oncology Group" with 1 trials as a collaborator, "Chinese Thoracic Oncology Group" with 1 trials as a collaborator, "Daiichi Sankyo Co., Ltd." with 1 trials as a collaborator and "Dutch Society of Physicians for Pulmonology and Tuberculosis" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were
collaborators in the rest 13 trials.
Clinical Trials Conditions at Japanese Red Cross Nagoya Daiichi Hospital
According to Clinical.Site data, the most researched conditions in "Japanese Red Cross Nagoya Daiichi Hospital" are
"Nocturia" (2 trials), "Rheumatoid Arthritis" (2 trials), "Aspergillosis, Aspergilloma" (1 trials), "Chronic Myelogenous Leukemia" (1 trials) and "Chronic Myeloid Leukemia" (1 trials). Many other conditions were trialed in "Japanese Red Cross Nagoya Daiichi Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Japanese Red Cross Nagoya Daiichi Hospital
Most popular intervention types in "Japanese Red Cross Nagoya Daiichi Hospital" are "Drug" (13 trials), "Device" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "A. Desmopressin 10 microgram" (1 trials), "Antithrombin gamma" (1 trials), "B: Desmopressin 25 microgram" (1 trials) and "Best Supportive Care" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Japanese Red Cross Nagoya Daiichi Hospital
The vast majority of trials in "Japanese Red Cross Nagoya Daiichi Hospital" are
13 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Japanese Red Cross Nagoya Daiichi Hospital
Currently, there are NaN active trials in "Japanese Red Cross Nagoya Daiichi Hospital".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in Japanese Red Cross Nagoya Daiichi Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Japanese Red Cross Nagoya Daiichi Hospital, 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 9 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".